» Articles » PMID: 32657101

Complications of Ceftriaxone-associated Biliary Pseudolithiasis and Neprolithiasis: a Case Report

Overview
Journal Cir Pediatr
Date 2020 Jul 14
PMID 32657101
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Ceftriaxone is a wide-spectrum antibiotic frequently used in pediatrics. Biliary pseudolithiasis is a well-known side-effect occurring in 15-57% of cases. However, nephrolithiasis is extremely infrequent, with very few related publications.

Case Report: We present the case of a 9-year-old patient with ceftriaxone-treated complicated acute appendicitis who developed biliary pseudolithiasis and nephrolithiasis. During hospitalization, the patient presented with pseudolithiasis complications such as mild pancreatitis and bilateral ureterohydronephrosis with acute renal failure.

Remarks: Suspecting ceftriaxone-associated biliary pseudolithiasis and/or nephrolithiasis is key to achieve an early diagnosis and prevent complications such as those reported in this patient. Early discontinuation is essential as an initial treatment measure.

Citing Articles

Splenic Infarctions and Sepsis Secondary to Ceftriaxone-Associated Acute Pancreatitis: A Case of Interdisciplinary Collaboration.

Rabin D, Spiro M, Rachford C, Fahey T, Farrell J Cureus. 2025; 16(12):e75592.

PMID: 39803005 PMC: 11724678. DOI: 10.7759/cureus.75592.


Cefazolin sodium pentahydrate cause urolithiasis: a case report and literature review.

Wang F, Nie W, Wang Z, Tian S, Dong J J Surg Case Rep. 2022; 2022(4):rjac115.

PMID: 35422990 PMC: 9004477. DOI: 10.1093/jscr/rjac115.